Indivior

Indivior

World Rank (Jan-05-2024)
5,511
Market Cap (Jan-05-2024)
2.101 Billion USD
World Rank (Jul-30-2023)
4,222
Market Cap (Jul-30-2023)
3.140 Billion USD
World Rank (Jan-07-2022)
5,892
Market Cap (Jan-07-2022)
2.206 Billion USD
World Rank (Jan-01-2021)
7,614
Market Cap (Jan-01-2021)
1.088 Billion USD
Company Rank in Country in 2023
Company rank in UK in July-2023 is 148
Headquarters Country
UK
Nasdaq / NYSE Code
INDV
Market Cap (Mar-08-2026)
4.03
World Region
Europe
World Subregion
Northern Europe
Annual Revenue in USD
901 Million USD
Annual Operating Income in USD
-91 Million USD
Annual Net Income in USD
-53 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
1,769 Million USD
Total Liabilities in USD
1,718 Million USD
Total Equity in USD
51 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Pharmaceutical
Company Website
INDIVIOR
Wikipedia
Wikipedia
Company Profile

Indivior is a global pharmaceutical company working to help change patients lives by pioneering life transforming treatment for substance use disorders and other serious mental illnesses. The company annual revenue is 647 million USD and total assets are 1,531 million USD as on 2020. The headquarters is in UK.

Annual Results Summary

INDIVIOR - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-20231,093-8 (Loss)2
Dec-2022901-91 (Loss)-53 (Loss)
Dec-2021791181205
Dec-2020647-156 (Loss)-148 (Loss)
Dec-2019785178134
Balance Sheet Summary

Total Assets as on Dec-2022 was 1,769 Million USD.

Total Liabilities as on Dec-2022 was 1,718 Million USD.

Total Equity as on Dec-2022 was 51 Million USD.

Founded Year
1994
Stock Exchange
LSE
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share